389 related articles for article (PubMed ID: 22807066)
1. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells.
Zhou CF; Li XB; Sun H; Zhang B; Han YS; Jiang Y; Zhuang QL; Fang J; Wu GH
IUBMB Life; 2012 Sep; 64(9):775-82. PubMed ID: 22807066
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level.
Kwon OH; Kang TW; Kim JH; Kim M; Noh SM; Song KS; Yoo HS; Kim WH; Xie Z; Pocalyko D; Kim SY; Kim YS
Biochem Biophys Res Commun; 2012 Jun; 423(1):38-44. PubMed ID: 22627140
[TBL] [Abstract][Full Text] [Related]
3. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice.
Shi HS; Li D; Zhang J; Wang YS; Yang L; Zhang HL; Wang XH; Mu B; Wang W; Ma Y; Guo FC; Wei YQ
Cancer Sci; 2010 Jun; 101(6):1447-53. PubMed ID: 20507318
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling.
Yang P; Li Z; Fu R; Wu H; Li Z
Cell Signal; 2014 Sep; 26(9):1853-62. PubMed ID: 24686087
[TBL] [Abstract][Full Text] [Related]
5. p,p'-Dichlorodiphenyltrichloroethane promotes aerobic glycolysis via reactive oxygen species-mediated extracellular signal-regulated kinase/M2 isoform of pyruvate kinase (PKM2) signaling in colorectal cancer cells.
Song L; Dong N; Li Z
Environ Toxicol; 2020 Mar; 35(3):333-345. PubMed ID: 31724279
[TBL] [Abstract][Full Text] [Related]
6. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
[TBL] [Abstract][Full Text] [Related]
7. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
[TBL] [Abstract][Full Text] [Related]
9. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
11. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase M2 accelerates pro-inflammatory cytokine secretion and cell proliferation induced by lipopolysaccharide in colorectal cancer.
Yang P; Li Z; Li H; Lu Y; Wu H; Li Z
Cell Signal; 2015 Jul; 27(7):1525-32. PubMed ID: 25778902
[TBL] [Abstract][Full Text] [Related]
13. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis.
Yu S; Zang W; Qiu Y; Liao L; Zheng X
Oncogene; 2022 Jan; 41(1):46-56. PubMed ID: 34671086
[TBL] [Abstract][Full Text] [Related]
15. Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase.
Mor I; Carlessi R; Ast T; Feinstein E; Kimchi A
Oncogene; 2012 Feb; 31(6):683-93. PubMed ID: 21725354
[TBL] [Abstract][Full Text] [Related]
16. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA 495810 promotes the aerobic glycolysis in colorectal cancer by stabilizing pyruvate kinase isozyme M2.
Cui K; Wu H; Zhang L; Li H; Israr G; Li Z
Int J Oncol; 2023 May; 62(5):. PubMed ID: 36960860
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2.
Jiang K; He B; Lai L; Chen Q; Liu Y; Guo Q; Wang Q
Int J Mol Med; 2012 Aug; 30(2):302-8. PubMed ID: 22580449
[TBL] [Abstract][Full Text] [Related]
19. miR-142-3p Modulates Cell Invasion and Migration via PKM2-Mediated Aerobic Glycolysis in Colorectal Cancer.
Ren J; Li W; Pan G; Huang F; Yang J; Zhang H; Zhou R; Xu N
Anal Cell Pathol (Amst); 2021; 2021():9927720. PubMed ID: 34336555
[TBL] [Abstract][Full Text] [Related]
20. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells.
Yan XL; Zhang XB; Ao R; Guan L
J Cell Biochem; 2017 Dec; 118(12):4792-4803. PubMed ID: 28543190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
